Difference between revisions of "NCCN guidelines"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 20: Line 20:
 
*'''2010:''' Shamieh et al. [https://doi.org/10.6004/Jnccn.2010.0124 Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697131/ PubMed]
 
*'''2010:''' Shamieh et al. [https://doi.org/10.6004/Jnccn.2010.0124 Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697131/ PubMed]
 
*'''2010:''' Hassen et al. [https://doi.org/10.6004/Jnccn.2010.0121 Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697128/ PubMed]
 
*'''2010:''' Hassen et al. [https://doi.org/10.6004/Jnccn.2010.0121 Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.] [https://pubmed.ncbi.nlm.nih.gov/20697128/ PubMed]
 +
 +
=Myeloid Growth Factor=
 +
*'''2005:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2005.0030 Myeloid growth factors clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038645/ PubMed]
 +
*'''2013:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2013.0148 Myeloid growth factors.] [https://pubmed.ncbi.nlm.nih.gov/24142827/ PubMed]
 +
*'''2009:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2009.0006 Myeloid growth factors.] [https://pubmed.ncbi.nlm.nih.gov/19176207/ PubMed]
 +
*'''2011:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2011.0075 Myeloid growth factors.] [https://pubmed.ncbi.nlm.nih.gov/21900221/ PubMed]
 +
*'''2007:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2007.0019 Myeloid growth factors. Clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/17335688/ PubMed]

Revision as of 16:43, 30 November 2023

This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Miscellaneous

Middle East and North Africa

Myeloid Growth Factor